Deal Announcement - Healthcare - PNP Pharmaceuticals

IMAP is pleased to announce that Capital West Partners – IMAP Canada has advised PNP Pharmaceuticals (“PNP”) on its sale to Gladius Partners.

Founded in 1999 in Burnaby, BC, PNP is a leading full-service contract manufacturer of nutraceuticals and pharmaceuticals for a diverse global customer base. The company provides a comprehensive array of services ranging from product development to warehousing and logistics, boasting one of the most highly accredited facilities in the industry. PNP has built a strong reputation for producing the highest quality products and premier customer service. This transaction will help propel its capabilities in a massive and growing market of consumers focused on health and wellness.

Gladius Partners is a Vancouver, BC based private equity firm focused on well-established, profitable mid-market businesses in the Pacific Northwest. The firm is focused on long-term value creation and success through their buy-and-hold strategy.

Capital West Partners – IMAP Canada’s team in Vancouver acted as exclusive financial advisor to PNP on this transaction and led a competitive sales process that generated interest from financial and strategic buyers.